Results 51 to 60 of about 18,559 (180)

Primary Cutaneous Gamma‐Delta T‐Cell Lymphoma Complicating Long‐Standing Immunosuppressed Dermatomyositis

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Primary cutaneous gamma‐delta T‐cell lymphoma (PCGD‐TCL) is a rare cytotoxic lymphoma with key oncogenic drivers in the JAK/STAT pathway. Also primarily involving the subcutaneous adipose tissue, subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) is more frequently encountered in scenarios of autoimmune disorders.
Bennett Christie‐Nguyen   +6 more
wiley   +1 more source

Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci

open access: yesBrazilian Journal of Infectious Diseases, 2015
Background: Vancomycin-resistant enterococci colonization has been reported to increase the risk of developing infections, including bloodstream infections.
Ahu Kara   +8 more
doaj   +1 more source

Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis   +54 more
wiley   +1 more source

Behçet Necatigil ile kısa bir söyleşi

open access: yes, 1970
Taha Toros Arşivi, Dosya No: 41-Behçet ...
Necatigil, Behçet
core  

Behçet Necatigil [PDF]

open access: yes, 1979
Taha Toros Arşivi, Dosya No: 41-Behçet ...

core  

Behçet Doğancı ile sözlü tarih görüşmesi

open access: yes, 2010
Bu görüşme, Aziz Elbas ve Ahmet Erdönmez koordinatörlüğünde Bursa Büyükşehir Belediyesi bünyesindeki Bursa Araştırmaları Merkezi tarafından Çarşının Öyküsü projesi başlığı altında gerçekleştirilmiştir.
Doğancı, Behçet
core   +1 more source

Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The majority of bimekizumab‐treated patients shifted from severe to mild and moderate IHS4 stages, and nearly 25% achieved an IHS4 of 0 by Week 48. Bimekizumab led to clinically meaningful improvements across IHS4 outcome measures. These data highlight an opportunity to address the need for effective treatments against draining tunnels.
Thrasyvoulos Tzellos   +15 more
wiley   +1 more source

Diversities between pediatric extra-pulmonary and pulmonary tuberculosis: a warning sign for the future

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2014
Background: Tuberculosis(TB) remains a major global health problem. The childhood tuberculosis has some unique features different which makes the diagnosis more complicated.
ilker devrim   +20 more
doaj  

Measuring success in HS treatment from the physician's and the patient's perspective

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Integrated clinician (HiSCR, IHS4, IHS4‐55, HS‐IGA) and patient (HiSQOL, DLQI) scores, combined with imaging‐based fibrosis and inflammation assessment, redefine treatment success in hidradenitis suppurativa by aligning treat‐to‐target strategies with both inflammatory control and irreversible structural damage.
Georgios Nikolakis   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy